Skip to main content



Mediwhale is an innovative retina-based AI company that autonomously assesses cardiovascular disease risk. With a simple eye scan using fundus cameras, the company’s AI algorithm analyzes the blood vessels in the retinal images and generates a future cardiovascular disease risk with comparable performance to a heart CT scan within a minute, providing a safe, affordable, and accessible solution at the point of care. Mediwhale also expands the coverage from cardiovascular disease to renal and metabolic diseases.

More News

  • Cardiac Rehabilitation Enabled With Health Technology: Innovative Models of Care Delivery and Policy to Enhance Health Equity

    Cardiac rehabilitation (CR) is a well‐established program for secondary prevention of cardiovascular…

  • Century of progress sets stage for future scientific advances in cardiovascular health

    Dramatic advances in the understanding and treatment of cardiovascular diseases have saved millions of…

  • Cardiovascular care centered on the patient is key and helps improve equity and outcomes

    Patient-centered care establishes a respectful partnership among the health care team, the…

  • Upcoming Webinar: Heart Talks: Navigating Vascular Aging for Heart Health 5/23!

    The CHTI is please to convene this group of experts on an…

Sign up for our mailing list